Skip to main content

Table 2 Antimicrobial resistance pattern for ESBL and Non- ESBL bacteria isolates, (% of resistance isolates within each group)

From: Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania

Antibiotic

E. coli

K. pneumoniae

E. cloacae

C. freundii

P. mirabilis

M. morganii

P. rettgeri

 

ESBL(+)

(n = 15)

ESBL (−)

(n = 95)

ESBL (+)

(n = 9)

ESBL (−)

(n = 18)

ESBL (+)

(n = 6)

ESBL (−)

(n = 5)

ESBL (+)

(n = 4)

ESBL (−)

(n = 5)

ESBL (+)

(n = 5)

ESBL (−)

(n = 2)

ESBL (+)

(n = 2)

ESBL (−)

(n = 5)

ESBL (−)

(n = 1)

AMC

NA

14.7

NA

44.4

NA

80

NA

50

NA

0

NA

20

100

CTX

NA

0.0

NA

0

NA

0

NA

0

NA

0

NA

0

0

CTZ

NA

0.0

NA

0

NA

0

NA

0

NA

0

NA

0

0

CRO

NA

1.1

NA

0

NA

0

NA

0

NA

0

NA

0

0

IMP

0

0

0

0

0

0

0

0

0

0

0

0

0

CHL

26.7

37.9

88.9

50

83.3

20

75

0

100

0

100

60

100

CIP

86.7

27.4

66.7

22.2

83.3

0

50

0

100

0

100

60

0

DO

100

73.7

66.7

44.4

83.3

60

100

40

100

100

100

80

100

CN

80

18

88.9

22.2

50

0

75

0

100

0

100

20

0

NAL

86.7

37.9

66.7

27.8

75

20

100

0

100

0

100

80

100

NIT

33.3

10.5

77.8

33.3

83.3

60

75

20

100

100

100

100

100

SXT

93.3

72.6

66.7

72.2

83.3

20

75

20

100

0

100

80

0

  1. AMC Amoxicillin-clavulanic acid, CTX cefotaxime, CTZ ceftazidime, CRO ceftriaxone, IMP imipenem, CHL chloramphenicol, CIP ciprofloxacin, DO doxycycline, CN gentamicin, NAL nalidixic acid, NIT nitrofurantoin, SXT trimethoprim-sulfamethoxazole
  2. NA Not applicable